EMBL Australia

Dr Senthil Arumugam recently joined EMBL Australia as a group leader, based at the Monash Biomedicine Discovery Institute.

An international team of scientists, led by EMBL Australia group leader Associate Professor Mikaël Martino, has cleared the way for the use of growth factors to promote tissue repair by improving the delivery system of the molecules, busting cancer side effects and potentially slashing costs.

Researchers from around the world – including a group from our Partner Laboratory Network – gathered by the sea in sunny Barcelona for the 3rd EMBL Partnership Conference, which aimed to foster collaboration within the wider EMBL network.

EMBL Australia group leader Associate Professor Max Cryle will lead the Victorian node of the new ARC Centre of Excellence for innovations in Peptide and Protein Science.

EMBL Australia Group Leaders participated in research talks, discussions and networking at the latest EMBL alumni event that was held in Brisbane.

Max Cryle and his team have revealed a novel mechanism in glycopeptide antibiotics (GPA) biosynthesis that may help in the development of new antibiotics. Their findings were published in Chemical Science.

Dr Martino has been awarded an NHMRC Investigator Grant to develop new regenerative strategies. He aims to reveal how the immune system influences the repair and regeneration of different tissues and organs, such as the heart and the lung.

The EMBL Australia PLN Secretariat hosted a visit from Director-General Jean-Eric Paquet, Research and Innovation, European Commission at Monash University on July 24th, followed by a public event at the National Gallery of Victoria with Prof James Whisstock, Scientific Head EMBL Australia, and Bernie Hobbs, ABC Broadcaster.

Australian PhD students in the life sciences are eligible to apply for one of 10 travel grants of $2000 to attend the 21st EMBL PhD Symposium in Heidelberg, Germany, on 28 to 30 November 2019.

New research by Group Leader Max Cryle about an unusual antibiotic has great implications for future antibiotics.